SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025
Rhea-AI Summary
SI-BONE Inc (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the 2025 BofA Securities Healthcare Conference in Las Vegas. The company's management will conduct a fireside chat on May 13, 2025, at 8:40 AM PT/11:40 AM ET. Investors can access the live webcast through a registration link or the company's website investor section. The webcast recording will remain available for replay for at least 90 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction – SIBN
On the day this news was published, SIBN gained 6.20%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 4,500 physicians in performing a total of over 120,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 160 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, sacropelvic fixation and pelvic trauma.
For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.
iFuse Bedrock Granite, iFuse TORQ, iFuse TORQ TNT, SI-BONE, and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal investors@si-bone.com
FAQ
When is SI-BONE (SIBN) presenting at the BofA Securities Healthcare Conference 2025?
How can investors access SI-BONE's (SIBN) presentation at the BofA Healthcare Conference?
How long will SI-BONE's (SIBN) BofA Healthcare Conference webcast be available for replay?
What does SI-BONE (SIBN) specialize in as a medical device company?
